Literature DB >> 7883995

The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children.

L J Bloem1, A K Manatunga, D A Tewksbury, J H Pratt.   

Abstract

The T235 allele of the angiotensinogen gene (AGT) has been associated with hypertension. Blood pressure increases faster over time in black children than in white children, and in adults hypertension is more prevalent in blacks. We sought evidence for a role for angiotensinogen to contribute to racial differences in blood pressure in a study of 148 white and 62 black normotensive children (mean age, 14.8 yr). The frequency of the T235 allele was 0.81 in blacks and 0.42 in whites (chi 2 = 77.3, P = 0.0001). The mean angiotensinogen level was 19% higher in blacks than in whites (P = 0.0001 for males, P = 0.004 for females). Genotype was positively related to serum angiotensinogen in white children (P = 0.0001 for males, P = 0.004 for females), but a similar relationship was absent in blacks where the frequency of M235 may have been too low to discern an association. Longitudinal blood pressure (measured twice yearly) adjusted for body mass index showed a marginally significant relationship to the angiotensinogen level (P = 0.07). An independent relationship of serum angiotensinogen with body mass index (P = 0.0001) and race (P = 0.0003) was also observed. In summary, T235 was more frequent, and the level of angiotensinogen was higher in blacks than in whites. Such a racial difference in the renin-angiotensin system may contribute to the disparity in blood pressure levels of white and black young people.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883995      PMCID: PMC441426          DOI: 10.1172/JCI117803

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Caucasian genes in American blacks: new data.

Authors:  R Chakraborty; M I Kamboh; M Nwankwo; R E Ferrell
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

2.  Racial differences in aldosterone excretion and plasma aldosterone concentrations in children.

Authors:  J H Pratt; J J Jones; J Z Miller; M A Wagner; N S Fineberg
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

3.  Evidence that angiotensin-II and potassium collaborate to increase cytosolic calcium and stimulate the secretion of aldosterone.

Authors:  J H Pratt; J K Rothrock; J H Dominguez
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

4.  DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA.

Authors:  L Madisen; D I Hoar; C D Holroyd; M Crisp; M E Hodes
Journal:  Am J Med Genet       Date:  1987-06

5.  High molecular weight angiotensinogen: a pregnancy associated protein.

Authors:  D A Tewksbury; E S Tryon; R E Burrill; R A Dart
Journal:  Clin Chim Acta       Date:  1986-07-15       Impact factor: 3.786

6.  Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog.

Authors:  J H Pratt
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

7.  Molecular basis of human hypertension: role of angiotensinogen.

Authors:  X Jeunemaitre; F Soubrier; Y V Kotelevtsev; R P Lifton; C S Williams; A Charru; S C Hunt; P N Hopkins; R R Williams; J M Lalouel
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

8.  Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats.

Authors:  L A Cassis
Journal:  Am J Physiol       Date:  1992-01

9.  Synthesis and release of immunoreactive angiotensinogen by rat liver slices.

Authors:  E Clauser; J Bouhnik; E Coezy; P Corvol; J Menard
Journal:  Endocrinology       Date:  1983-04       Impact factor: 4.736

10.  Location and regulation of rat angiotensinogen messenger RNA.

Authors:  L A Cassis; J Saye; M J Peach
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

View more
  40 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.

Authors:  A M Sharma; S Engeli; T Pischon
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 3.  The renin-angiotensin system in blacks: active, passive, or what?

Authors:  Deborah A Price; Naomi D L Fisher
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 4.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 5.  Control of energy balance by the brain renin-angiotensin system.

Authors:  Kristin E Claflin; Justin L Grobe
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

6.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

7.  Renin-angiotensin gene polymorphism in children with uremia and essential hypertension.

Authors:  Ferenc Papp; Aaron L Friedman; Csaba Bereczki; Ibolya Haszon; Eva Kiss; Emöke Endreffy; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2002-12-18       Impact factor: 3.714

Review 8.  Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

Authors:  Nicole K Littlejohn; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

9.  Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population.

Authors:  K G Nair; K K Shalia; T F Ashavaid; J J Dalal
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

10.  PPARs in the Renal Regulation of Systemic Blood Pressure.

Authors:  Tamás Roszer; Mercedes Ricote
Journal:  PPAR Res       Date:  2010-06-08       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.